临床特征、定性影像生物标志物及肿瘤氧合影像生物标志物用于鉴别成人中线IDH野生型胶质母细胞瘤与H3 K27变异型弥漫性中线胶质瘤
本研究纳入55例成人中线IDH野生型胶质母细胞瘤或H3 K27变异型弥漫性中线胶质瘤患者,比较临床、定性和定量影像表型(包括肿瘤氧合特征)。多变量分析显示年龄、丘脑或延髓位置、坏死存在及氧摄取分数为独立预测因子,模型AUC为0.88。作者认为较低氧摄取分数等影像生物标志物可能有助于鉴别。
要点
- 丘脑或延髓位置是鉴别H3 K27变异型弥漫性中线胶质瘤的独立预测因子(OR=10.48)。
- 坏死存在(OR=0.15)和较低氧摄取分数(OR=0.01)与H3 K27变异型弥漫性中线胶质瘤相关。
- 多变量模型鉴别AUC为0.88,准确率81.8%,敏感度82.6%,特异度81.3%。
核心结论
- 除较年轻年龄、肿瘤位置、坏死较少见外,较低氧摄取分数可能是鉴别H3 K27变异型弥漫性中线胶质瘤与中线IDH野生型胶质母细胞瘤的有用影像生物标志物。
研究设计与样本
- 回顾性纳入55例成人患者术前MRI数据,包括32例IDH野生型胶质母细胞瘤和23例H3 K27变异型弥漫性中线胶质瘤,进行定性影像评估和基于肿瘤掩模自动分割的定量影像评估。
关键影像表现/征象
- 坏死存在与IDH野生型胶质母细胞瘤相关(OR=0.15,P=0.038)。
- 丘脑或延髓位置与H3 K27变异型弥漫性中线胶质瘤相关(OR=10.48,P=0.013)。
- 肿瘤氧合影像生物标志物可能反映H3 K27变异型弥漫性中线胶质瘤比IDH野生型胶质母细胞瘤缺氧程度更轻。
诊断标准与关键数值
- 多变量模型鉴别H3 K27变异型弥漫性中线胶质瘤与中线IDH野生型胶质母细胞瘤的AUC为0.88(95%CI:0.77-0.95)。
- 多变量模型准确率为81.8%,敏感度为82.6%,特异度为81.3%。
- 年龄的OR=0.92(P=0.015),丘脑或延髓位置的OR=10.48(P=0.013),坏死的OR=0.15(P=0.038),氧摄取分数的OR=0.01(P=0.042)。
临床应用与阅片要点
- 作者认为,结合较年轻年龄、肿瘤位置、坏死较少见和较低氧摄取分数,可能有助于鉴别H3 K27变异型弥漫性中线胶质瘤与中线IDH野生型胶质母细胞瘤。
- 肿瘤氧合影像生物标志物可能反映H3 K27变异型弥漫性中线胶质瘤缺氧程度较轻,并可能有助于鉴别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the clinical, qualitative and quantitative imaging phenotypes, including tumor oxygenation characteristics of midline-located IDH-wildtype glioblastomas (GBMs) and H3 K27-altered diffuse midline gliomas (DMGs) in adults.
METHODS: Preoperative MRI data of 55 adult patients with midline-located IDH-wildtype GBM or H3 K27-altered DMG (32 IDH-wildtype GBM and 23 H3 K27-altered DMG patients) were included. Qualitative imaging assessment was performed. Quantitative imaging assessment including the tumor volume, normalized cerebral blood volume, capillary transit time heterogeneity (CTH), oxygen extraction fraction (OEF), relative cerebral metabolic rate of oxygen values, and mean ADC value were performed from the tumor mask via automatic segmentation. Univariable and multivariable logistic analyses were performed.
RESULTS: On multivariable analysis, age (odds ratio [OR] = 0.92, P = 0.015), thalamus or medulla location (OR = 10.48, P = 0.013), presence of necrosis (OR = 0.15, P = 0.038), and OEF (OR = 0.01, P = 0.042) were independent predictors to differentiate H3 K27-altered DMG from midline-located IDH-wildtype GBM. The area under the curve, accuracy, sensitivity, and specificity of the multivariable model were 0.88 (95 % confidence interval: 0.77-0.95), 81.8 %, 82.6 %, and 81.3 %, respectively.
CONCLUSIONS: Along with younger age, tumor location, less frequent necrosis, and lower OEF may be useful imaging biomarkers to differentiate H3 K27-altered DMG from midline-located IDH-wildtype GBM. Tumor oxygenation imaging biomarkers may reflect the less hypoxic nature of H3 K27-altered DMG than IDH-wildtype GBM and may contribute to differentiation.
引用
- Sim Y, Choi SH, Lee N, et al. Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults. Eur J Radiol. 2024. PMID: 38422610. doi:10.1016/j.ejrad.2024.111384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。